Iclusig 30MG tab (NDC: 63020-0533-30)
Ended Awarded
- Contract number
- 36C26124F0262
- Awardee
-
Takeda Pharmaceuticals America, Inc. UEI ENNFDLWFC6L1
- Awarding agency
-
Veterans Integrated Service Network 21
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $14,409
Award facts
- Contract value 99% obligated
- $14,490.39 Current and potential, with all options
- Completion date
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Fresno, CA 93703, USA
Award details come from SAM.gov/FPDS.
About this award
This federal contract award is for ICLUSIG 30MG TAB (NDC: 63020-0533-30), a specialty pharmaceutical product, to the Department of Veterans Affairs Veterans Health Administration. The prime contractor is Takeda Pharmaceuticals America, Inc., a foreign-owned, for-profit manufacturer of pharmaceutical goods. The contract has a firm fixed price of $14,490.39 and a completion date of March 18, 2024. It was awarded under Takeda's General Services Administration (GSA) Schedule 61-IB for Pharmaceuticals and Drugs, which serves as a master contract vehicle for the VA and other federal agencies to efficiently procure specialty medications. This award is not designated as a set-aside contract. Takeda Pharmaceuticals America, as a subsidiary of the global biopharmaceutical company Takeda Pharmaceutical Company Limited, provides oncology medications and other pharmaceutical products to VA medical facilities and hospital networks across the country to support the healthcare needs of veterans.
Quick answers
Who was awarded contract 36C26124F0262?
36C26124F0262 was awarded to Takeda Pharmaceuticals America, Inc. by Veterans Integrated Service Network 21 (Veterans Health Administration) on March 18, 2024.
How much is contract 36C26124F0262 worth?
The government has obligated $14,409 on 36C26124F0262. Its current value, with exercised options, is $14,490.
Is contract 36C26124F0262 an order under another contract?
Yes. 36C26124F0262 is a delivery order under 36F79718D0586, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26124F0262 competed?
The extent of competition for 36C26124F0262 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award